Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton's tyrosine kinase inhibitor.
Amit Bar-OrAnne H CrossAnthony L CunninghamYann HyvertAndrea SeitzingerHans GühringElise E DrouinNektaria AlexandriDavorka TomicXavier MontalbanPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
and recall antigens is maintained.